**11. Management**

Firm diagnosis of EoE is essential before offering any treatment. Symptomatic esophageal eosinophilia is now considered as EoE when other secondary/non-EoE causes are excluded [30]. Few years ago, the term proton pump inhibitor responsive esophageal eosinophilia (PPI REE) was used [31] but EoE and PPIREE are indistinguishable clinically, endoscopically and pathologically. The term PPI-REE is no longer used at the present time. The main aim of treatment of EoE is not only clinical improvement but also histological improvement to prevent development of esophageal stricture. In 2020, the American Gastroenterology Association (AGA) and the Joint Task Force on Allergy-Immunology Practice Parameters (JTF) recommended certain guidelines on the management of EoE [32]. Currently, drugs, diet and dilation are the three main modalities of treatment of EoE.
